Interviewtimes 
The Serum Institute of India (SII) has called on US President Joe Biden to lift sanctions on raw materials needed for the vaccine. The White House has said no action will be taken. Due to the shortage of raw materials, Covishield is unable to produce the necessary vaccines. He urged the U.S. government to lift sanctions on raw materials.
“His country is focusing more on covaxin,” said Dr. Andy Slacit, a senior White House co-ordinator. The United States has agreed to send the covaxin vaccine to other countries. We are emphasizing it. “We can no longer cooperate on this issue,” said Dr. Anthony Fausi, another White House official and director of the National Institute of Allergies. We will comment on this later.
Indian Ambassador to the United States Taranjit Singh Sidhu is constantly discussing the raw materials needed for India in front of the US authorities. He informed the US administration about the situation in India and demanded that the raw materials be supplied as soon as possible. In addition, the United States has said there are no restrictions on the export of raw materials related to vaccines.
But the United States is doing just that. Then thinking about exports. According to sources close to the U.S. government, the Biden administration has assured New Delhi that efforts will be made to resolve the issue as soon as possible.
Notably, former President Donald Trump enacted the Defense Production Act after the Corona crisis. Which is also supported by the Biden government. This policy means ‘America First’. So American companies have to focus on meeting the needs of their country first. The United States is pushing for the production of phytosanitary and modern vaccines. Because by July 8, the United States aims to vaccinate the entire population. So even if the United States can’t afford the raw materials needed to make vaccines from other countries, including India, it can’t.
Now the Indian government has decided to vaccinate all adults from May 1. However, the company that makes the vaccine has not yet received the raw material. In India, the government is paying close attention to the vaccine.
